CDC42 and cancer: Specifically, reduced Cdc42 levels lead to decreased F-actin content, which, in turn, frees up LATS1, allowing it to bind to and phosphorylate YAP, thereby inactivating it and reducing its nuclear accumulation, finally leading to attenuated cancer cell proliferation [15].